|
OCX
|
OncoCyte Corporation
|
0.01%
|
US
|
NASDAQ
|
|
CYT
|
Cyteir Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
TNXP
|
Tonix Pharmaceuticals Holding Corp.
|
0.00%
|
US
|
NASDAQ
|
|
TERN
|
Terns Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
SYRS
|
Syros Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
SPRO
|
Spero Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
SNSE
|
Sensei Biotherapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
RDHL
|
Redhill Biopharma Ltd.
|
0.00%
|
US
|
NASDAQ
|
|
PRQR
|
ProQR Therapeutics B.V.
|
0.00%
|
US
|
NASDAQ
|
|
ONCR
|
Oncorus, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
OBSV
|
ObsEva SA
|
0.00%
|
US
|
NASDAQ
|
|
NRXP
|
NeuroRx, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
NLTX
|
Neoleukin Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
MTEM
|
Molecular Templates, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
MBIO
|
Mustang Bio, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
LRMR
|
Larimar Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
LABP
|
Landos Biopharma, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
INFI
|
Infinity Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
CNTB
|
Connect Biopharma Holdings Limited
|
0.00%
|
US
|
NASDAQ
|